Although the chief of the World Health Organization (WHO) has declared the end of the coronavirus disease 2019 (COVID-19) as a global health emergency, the disease is still a global threat. To be able to manage such pandemics in the future, it is necessary to develop proper strategies and opportunities to protect human life. The data on the SARS-CoV-2 virus must be continuously analyzed, and the possibilities of mutation and the emergence of new, more infectious variants must be anticipated, as well as the options of using different preventive and therapeutic techniques. This is because the fast development of severe acute coronavirus 2 syndrome (SARS-CoV-2) variants of concern have posed a significant problem for COVID-19 pandemic control using the presently available vaccinations. This review summarizes data on the SARS-CoV-2 variants that are responsible for severe COVID-19 and the clinical efficacy of the most commonly used vaccines in clinical practice. The consequences after the disease (long COVID or post-COVID conditions) continue to be the subject of studies and research, and affect social and economic life worldwide.

The bidirectional communication network between the gut and the brain, known as the gut–brain axis, plays a crucial role in health and disease. This review explores the mechanisms underlying gut–brain interaction disorders and highlights translational therapies bridging neurology and gastroenterology. Mechanisms encompass anatomical, endocrine, humoral, metabolic, and immune pathways, with the gut microbiota exerting profound influence. Clinical evidence links gut microbiota fluctuations to mood disorders, GI disruptions, and neurodevelopmental conditions, emphasizing the microbiome’s pivotal role in shaping brain–gut interactions. Pharmacological therapies such as amitriptyline and selective serotonin reuptake inhibitors modulate neurotransmitter activity, offering relief in functional gastrointestinal disorders like irritable bowel syndrome (IBS). Non-pharmacological interventions like cognitive–behavioral therapy and hypnotherapy address maladaptive thoughts and induce relaxation, alleviating gastrointestinal symptoms exacerbated by stress. Emerging therapies include gut microbiota modulation, dietary interventions, vagus nerve stimulation, and intestinal barrier modulation, offering novel approaches to manage neurological disorders via the gastrointestinal tract. Understanding and harnessing the gut–brain axis holds promise for personalized therapeutic strategies in neurogastroenterology.

Information about the fungal composition of bee bread, and the fermentation processes to which the fungi contribute significantly, is rather scarce or fragmentary. In this study, we performed an NGS-based metagenomics snapshot picture study of the fungal composition of bee bread in four locations in Bulgaria during the most active honeybee foraging period at the end of June 2020. The sampling locations were chosen to differ significantly in climatic conditions, landscape, and anthropogenic pressure, and the Illumina 2 × 250 paired-end reads platform was used for amplicon metagenomics study of the ITS2 region. We found that some of the already reported canonical beneficial core fungal species were present within the studied samples. However, some fungal genera such as Monilinia, Sclerotinia, Golovinomyces, Toxicocladosporium, Pseudopithomyces, Podosphaera and Septoriella were reported for the first time among the dominant genera for a honeybee related product. Anthropogenic pressure negatively influences the fungal composition of the bee bread in two different ways—urban/industrial pressure affects the presence of pathogenic species, while agricultural pressure is reflected in a decrease of the ratio of the beneficial fungi.

In spite of the increasing industrial cultivation of lavender (Lavandula angustifolia Mill.), no genetic linkage map and mapping of QTLs (quantitative trait locus) has been reported for Lavandula species. We present the development of a set of SSR (simple sequence repeat) markers and the first genetic linkage map of lavender following the genotyping of a segregating population obtained by the self-pollination of the industrial lavender variety Hemus. The resulting genetic map comprises 25 linkage groups (LGs) corresponding to the chromosome number of the lavender reference genome. The map includes 375 loci covering a total of 2631.57 centimorgan (cM). The average marker distance in the established map is 7.01 cM. The comparison of the map and reference genome sequence shows that LG maps cover an average of 82.6% of the chromosome sequences. The PCR amplification tests suggest that the developed SSR marker set possesses high intra-species (>93%) and inter-species (>78%) transferability. The QTL analysis employing the constructed map and gas chromatography/mass spectrometry (GC/MS) dataset of flower extracted volatiles resulted in the mapping of a total of 43 QTLs for the accumulation of 25 different floral volatiles. The comparison of the genome location of the QTLs and known biosynthetic genes suggests candidate genes for some QTLs.

Although there are numerous available immunomodulators, those of natural origin would be preferable based on their safety profile and effectiveness. The research and clinical interest in immunomodulators have increased in the last decades, especially in the immunomodulatory properties of plant-based therapies. Innovative technologies and extensive study on immunomodulatory natural products, botanicals, extracts, and active moieties with immunomodulatory potential could provide us with valuable entities to develop as novel immunomodulatory medicines to enhance current chemotherapies. This review focuses on plant-based immunomodulatory drugs that are currently in clinical studies. However, further studies in this area are of utmost importance to obtain complete information about the positive effects of medicinal plants and their chemical components and molecules as an alternative to combatting various diseases and/or prevention.

An amplicon-based metagenomic survey of archaea, fungi, and bacteria was performed on Livingston Island, Maritime Antarctica. In many of the samples, patterns of antagonism between these three superkingdoms were observed in the form of an inversely proportional dependence of the richnesses of the three types of microorganisms. The antagonism was quantified—based on the observed numbers of the total tags and the numbers of the operational taxonomic units (OTUs), and on four alpha diversity parameters—using the Shannon, the Simpson, the Chao1, and the ACE indices. We found that the most discriminative results in the antagonism measuring were obtained when the numbers of the OTUs and the ACE community richness estimator were compared. The antagonism between archaea and fungi was most potent, followed by that of archaea and bacteria. The fungi–bacteria antagonism was slightly detectable. Pearson and Spearman correlation analyses also showed a statistically significant negative correlation between the fungal and archaeal effective tags, while the correlation between archaeal and bacterial diversity was positive. Indications of the order of primary microbial succession in barren ecological niches were also observed, demonstrating that archaea and bacteria are the pioneers, followed by fungi, which would displace archaea over time.